All Journals > The Journal of Infectious Diseases > 15 November 2006 > CMV‐Specific T Cell Functionality

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 November 2006

Volume 194, Number 10
The Journal of Infectious Diseases 2006;194:1410–1421
0022-1899/2006/19410-0010$15.00
DOI: 10.1086/508495
MAJOR ARTICLE

Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate‐Early Antigen Polypeptides in Hematopoietic Stem‐Cell Transplant and Solid Organ Transplant Recipients

Simon F. Lacey,1

Corinna La Rosa,1

Wendy Zhou,1

Madeva C. Sharma,1

Joy Martinez,1

Aparna Krishnan,1

Ghislaine Gallez‐Hawkins,2

Lia Thao,2

Jeff Longmate,3

Ricardo Spielberger,4

Stephen J. Forman,4

Ajit Limaye,5

John A. Zaia,2 and

Don J. Diamond1

1Laboratory of Vaccine Research, 2Division of Virology, and 3Department of Biostatistics, Division of Information Sciences, Beckman Research Institute of the City of Hope, and 4Department of Hematology and Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California; 5Departments of Laboratory Medicine and Medicine, University of Washington, Seattle

The functional status of cytotoxic T lymphocyte (CTL) populations recognizing cytomegalovirus intermediate‐early antigen (IE1) and pp65 polypeptides was investigated in peripheral blood mononuclear cells from hematopoietic stem‐cell transplant (HSCT) and solid organ transplant recipients. Combined flow‐based CD107a/b degranulation/mobilization and intracellular cytokine (ICC) assays using peptide libraries as antigens indicated that a significantly higher proportion of pp65‐specific CTLs were in a more mature functional state, compared with IE1‐specific CTLs. Degranulation/multiple cytokine ICC assays also indicated that a significantly higher proportion of pp65‐specific than IE1‐specific CTLs secreted both interferon‐γ and tumor necrosis factor–α and possessed greater cytotoxic potential. These results support our earlier findings of functional differences between CTLs recognizing individual epitopes within the IE1 and pp65 antigens in healthy donors and HSCT recipients and extend them to a broader array of human leukocyte antigen–restricted responses to those antigens. We also provide evidence of a relationship between cytotoxic function and the ability of cytomegalovirus‐specific CTLs to secrete multiple cytokines.

Received 16 May 2006; accepted 18 July 2006; electronically published 11 October 2006.

Reprints or correspondence: Dr. Simon F. Lacey, Laboratory of Vaccine Research, Rm. 1001c, Fox South Blvd., Beckman Research Institute of the City of Hope, 1450 E. Duarte Rd., Duarte, CA 91010‐3000 ().

Cited by

W. Zhou, J. Longmate, S. F. Lacey, J. M. Palmer, G. Gallez-Hawkins, L. Thao, R. Spielberger, R. Nakamura, S. J. Forman, J. A. Zaia, D. J. Diamond. (2009) Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood 113:25, 6465-6476
Online publication date: 18-Jul-2009.
CrossRef
B Pourgheysari, K P Piper, A McLarnon, J Arrazi, R Bruton, F Clark, M Cook, P Mahendra, C Craddock, P A H Moss. (2009) Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplantation 43:11, 853-861
Online publication date: 1-Jul-2009.
CrossRef
G. Nebbia, F. M. Mattes, C. Smith, E. Hainsworth, J. Kopycinski, A. Burroughs, P. D. Griffiths, P. Klenerman, V. C. Emery. (2009) Polyfunctional Cytomegalovirus-Specific CD4+ and pp65 CD8+ T Cells Protect Against High-Level Replication After Liver Transplantation. American Journal of Transplantation 8:12, 2590-2599
Online publication date: 1-Jan-2009.
CrossRef
Véronique Mersseman, Verena Böhm, Rafaela Holtappels, Petra Deegen, Uwe Wolfrum, Bodo Plachter, Sabine Reyda. (2008) Refinement of strategies for the development of a human cytomegalovirus dense body vaccine. Medical Microbiology and Immunology 197:2, 97-107
Online publication date: 1-Jul-2008.
CrossRef
Corinna La Rosa, Aparna Krishnan, Jeff Longmate, Joy Martinez, Pooja Manchanda, Simon F. Lacey, Ajit P. Limaye, and Don J. Diamond. (2008) Programmed Death–1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease. The Journal of Infectious Diseases 197:1, 25-33
Online publication date: 1-Jan-2008.
D. Lilleri, P. Zelini, C. Fornara, G. Comolli, G. Gerna. (2007) Inconsistent Responses of Cytomegalovirus-Specific T Cells to pp65 and IE-1 versus Infected Dendritic Cells in Organ Transplant Recipients. American Journal of Transplantation 7:8, 1997-2005
Online publication date: 1-Sep-2007.
CrossRef
  • Potential conflicts of interest: none reported.

    Financial support: National Institutes of Health (grants P01‐CA30206 to S.J.F., J.A.Z., and D.J.D.; R01‐CA77544 to D.J.D.; R01‐AI058148 to J.A.Z.; and M01‐RR00043‐38 in support of the General Clinical Research Center at City of Hope); Leukemia and Lymphoma Society (award 6122‐02 to S.F.L. and Comprehensive Cancer Center grant CA33572 to City of Hope); Edwin and Bea Wolfe Charitable Foundation (support to the Laboratory of Vaccine Research).

Close Popup